Draeger announces FDA clearance for new ventilator--Carina[TM].
Draeger Medical Systems, Inc., announced that it has received 510(k) clearance from the FDA to market the Carina, Draeger's latest product in its ventilator product line to the US market. The Carina ventilator offers both invasive and noninvasive capabilities in one device. Its latest technology known as "Synch Plus" will compensate for leakage and provide: effective breath delivery. The Carina is well suited for the emergency room, general ward, ICU, or sub-acute facilities as it features an internal battery and can operate independent of a high pressure gas system.
"This will allow clinicians a wide array of ventilation therapies in a single device characterized by ease of use and patient comfort. The transportability of the Carina makes patient transfer seamless and expedient especially when a patient requires nor-invasive support" said Ed Coombs, MA RRT, Director, Critical Care and Ventilation for Draeger Medical, Inc.
For patients who are mechanically ventilated long term, the Carina-home facilitates similar style ventilation technology for chronic patients outside of the hospital. The Carina-home has been in the US marketplace for over a year. The Carina is expected to be commercially available by July 2008 in the US.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||INDUSTRY NEWS|
|Publication:||FOCUS: Journal for Respiratory Care & Sleep Medicine|
|Article Type:||Brief article|
|Date:||May 1, 2008|
|Previous Article:||Caring for acrylics.|
|Next Article:||Scripps Memorial Hospital nurses throw out union.|